Private equity firms Bain Capital and Cinven are exploring a potential joint bid for Sanofi’s $20B consumer health division, people familiar with the matter told Bloomberg’s Dinesh Nair, Swetha Gopinath and Pamela Barbaglia. Advent International is speaking to potential partners, including sovereign wealth fund Abu Dhabi Investment Authority, about teaming up for its own planned offer, the sources said. Sanofi announced plans in October 2023 to review all options to split the consumer health unit, which sells over-the-counter products.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Sanofi Advances Polio Eradication with Biovac Partnership
- Sanofi price target raised to EUR 120 from EUR 115 at Jefferies
- Sanofi says frexalimab reduced biomarker of nerve cell damage in Phase 2 data
- Sanofi: Fexalimab Ph2 data showed lower key biomarker of nerve cell damage
- Sanofi investing $400M in Vigil Neuroscience, says Guggenheim